Previous studies have shown that luteolin affects asthma via the induction of FOXP3+ and CD4+CD25+ Tregs or acts as an immunosuppressant mTOR inhibitor to increase the percentage of CD4+FOXP3+ Tregs posttransplantation [29]. The gene discussed is CD4; the disease is asthma.